The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BBIO · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
AQST · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | BBIO | CFOR | AQST | MLAB |
|---|---|---|---|---|
| Moat Score (0–100) | 50 (highest) | 50 (highest) | 50 (highest) | 50 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 58 | 80 (highest) | 29 | 68 |
| Pricing power | 91 | 49 | 93 | 98 (highest) |
| Returns on capital | — | 6 (highest) | — | 0 |
| Balance-sheet safety | 28 | 73 (highest) | 55 | 42 |
| Capital discipline | 24 | 44 (highest) | 24 | 43 |
| Price vs. high estimate | No price data | No price data | No price data | 32% above high estimate |
| Market cap | $15.7B | $142.1M | $481.5M | $534.1M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2026 |